The electrophysiology ablation catheters market has seen considerable growth due to a variety of factors.
• In recent times, the electrophysiology ablation catheters market has seen a swift expansion. The market size which stood at $3.49 billion in 2024 is expected to reach $4.11 billion by 2025, growing at a compound annual growth rate (CAGR) of 17.8%.
The market growth seen in the historic period is due to several factors including the increased incidence of cardiac arrhythmias, the rise in the elderly population, the escalating demand for minimally invasive procedures, advancements in imaging technology, and the growth of the healthcare infrastructure.
The electrophysiology ablation catheters market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the electrophysiology ablation catheters market is projected to experience a significant increase. By 2029, this growth will equate to a market worth of $7.83 billion, achieved at a compound annual growth rate (CAGR) of 17.5%.
This expected growth during the forecast period is linked to factors such as the rising number of cardiac arrhythmia cases, more widespread use of minimally invasive techniques, heightened recognition of early detection, support from governmental bodies, and an increase in the elderly population suffering from severe cardiac problems. Prevailing trends for the forecast timeline involve the incorporation of superior imaging technologies, progress in design and material of catheters, application of telemedicine for remote observation and consultations, improved integration of wearable tech for constant cardiac tracking, and instantaneous tracking and data analytics application in electrophysiology methods.
The escalating prevalence of individuals with cardiac rhythm disorders is projected to fuel the expansion of the electrophysiology ablation catheter market. These patients are affected by erratic heartbeats, also termed as arrhythmia. The surge in this patient demographic can be attributed to aging demographics, weight gain trends, and heightened incidence of cardiac maladies. Electrophysiology ablation catheters come into play by eradicating the irregular heart tissue that precipitates inconsistent heartbeats, and subsequently reinstating a normal rhythm. As per the Heart Rhythm Society, a non-profit group based in the United States, atrial fibrillation (AFib) is a significant global burden, impacting almost 40 million people around the globe, inclusive of nearly 6 million in the United States alone. By the year 2030, the count of individuals with AFib in the U.S. is anticipated to climb to 12.1 million. Consequently, this surge in heart rhythm disorder cases will catalyze the growth of the electrophysiology ablation catheter market.
The electrophysiology ablation catheters market covered in this report is segmented –
1) By Product: Lab Devices, Ablation Catheters, Diagnostic Catheters
2) By Indication: Atrial Fibrillation (AF), Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Wolff-Parkinson-White (WPW)
3) By End-User: Hospitals, Ambulatory Surgery Centers (ASCs)
Subsegments:
1) By Lab Devices: Electrophysiology Mapping Systems, Ablation System Generators, Catheter Visualization Systems, Recording And Monitoring Systems, 3D Mapping Systems, Electroanatomical Mapping Systems
2) By Ablation Catheters: Radiofrequency Ablation Catheters, Cryoablation Catheters, Laser Ablation Catheters, Microwave Ablation Catheters, Pulsed Field Ablation Catheters, Catheters With Irrigation Features
3) By Diagnostic Catheters: Diagnostic Mapping Catheters, Electrogram Recording Catheters, Multi-Electrode Diagnostic Catheters, Steerable Diagnostic Catheters, Catheters For Intracardiac Electrogram Monitoring, Catheters For Signal Acquisition And Interpretation
Major participants in the electrophysiology ablation catheter market are pioneering technological advancements such as multi-channel radiofrequency (RF) generators. The goal is to increase precision, better the results of treatments, and more effectively manage complicated arrhythmias. Multi-channel RF generators are instruments that simultaneously generate several RF signals, which precisely target and treat specific areas in medical or industrial use. For example, Biosense Webster, a medical device company based in the US, unveiled the HELIOSTAR Balloon Ablation Catheter in Europe in October 2022. The HELIOSTAR is the first-of-its-kind radiofrequency balloon ablation catheter which is meant for catheter-based cardiac electrophysiological mapping of the atria and cardiac ablation when used in coordination with a suitable multi-channel RF generator. It perfectly aligns with Biosense Webster's CARTO 3 System, a 3D mapping solution. The HELIOSTAR has a flexible balloon which can adapt to variable pulmonary vein anatomy, allowing for single-shot pulmonary vein isolation (PVI) in approximately 12 seconds.
Major companies operating in the electrophysiology ablation catheters market are:
• Johnson & Johnson
• Abbott Laboratories
• Medtronic plc
• Siemens Healthineers AG
• Koninklijke Philips N.V.
• Stryker Corporation
• General Electric Company
• Boston Scientific Corporation
• Edwards Lifesciences Corporation
• Zoll Medical Corporation
• Integra LifeSciences Holdings Corporation
• Merit Medical Systems Inc.
• Conmed Corporation
• MicroPort Scientific Corporation
• AtriCure Inc.
• AngioDynamics Inc.
• Esaote S.p.A.
• Stereotaxis Inc.
• APN Health LLC
• Kardium Inc.
• Hansen Medical Inc.
• Acutus Medical Inc.
• Imricor Medical Systems Inc.
• Osypka Medical GmbH
North America was the largest region in the electrophysiology ablation catheters market in 2024. The regions covered in the electrophysiology ablation catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.